Aspergillus identification through bronchoscope in intensive care unit – a retrospective, databased cohort study
Frontiers in Cellular and Infection Microbiology · 2025
DOI: 10.3389/fcimb.2024.1471298 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Hsin-I Cheng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan. Hauptthemen laut MEDLINE: Intensive Care Units, Aspergillus, Bronchoscopy, Invasive Pulmonary Aspergillosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Intensivpflege
Abstract (Originalsprache)
Introduction
Invasive pulmonary aspergillosis (IPA) increases the risk of mortality of critically ill patients. Diagnostic criteria specifically targeting patients in intensive care units(ICUs) have been developed to improve diagnostic sensitivity. This study investigated health outcomes among patients in ICUs with Aspergillus isolates identified using bronchoscopy.
Methods
This retrospective cohort study obtained data from the Chang Gung Research Database of Chang Gung Memorial Hospital. Patients admitted to the ICU between January 2017 and December 2022 who received bronchoalveolar lavage were enrolled. Patients with a fungus culture yielding Aspergillus spp. isolates or who had an Aspergillus galactomannan antigen index value of >1.0 were categorized into the Aspergillus-positive group.
Results
A total of 2372 patients were enrolled, and 146 patients (6.16%) tested positive for Aspergillus. Of the patients who tested positive for Aspergillus, 37.67% had a positive culture result, and 77.4% had a positive galactomannan antigen result. Patients with Aspergillus isolates were more likely to have a recent influenza infection, concurrent bacterial sepsis, and a cavitation and to die in hospital (in-hospital mortality rate 58.9% vs. 48.57%, P = 0.016).
Discussion
Identifying Aspergillus through bronchoscopy in the ICU is associated with higher mortality rates than in patients who test negative for Aspergillus. Galactomannan antigen from bronchoalveolar lavage may provide higher diagnostic sensitivity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
- School of Medicine, Chang Gung University, Taoyuan, Taiwan.
- Department of Respiratory Therapy, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
- School of Medicine, National Tsing Hua University, Hsin-Chu, Taiwan.
- Center for Big Data Analytics and Statistics, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Zitieren
APA
Cheng, H. I., Lin, C. Y., Lin, H. C., Lin, S. M., Hsieh, M. H., Fang, Y. F., Chang, P. J., Hung, W. S., Cheng, K., & Huang, C. C. (2025). Aspergillus identification through bronchoscope in intensive care unit – a retrospective, databased cohort study. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1471298
Vancouver
Cheng HI, Lin CY, Lin HC, Lin SM, Hsieh MH, Fang YF, et al. Aspergillus identification through bronchoscope in intensive care unit – a retrospective, databased cohort study. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2024.1471298
BibTeX
@article{Cheng2025,
author = {Cheng, Hsin-I and Lin, Chun-Yu and Lin, Horng-Chyuan and Lin, Shu-Min and Hsieh, Meng-Heng and Fang, Yueh-Fu and Chang, Po-Jui and Hung, Wei-Syun and Cheng, Ko and Huang, Chung Chi},
title = {Aspergillus identification through bronchoscope in intensive care unit – a retrospective, databased cohort study},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
doi = {10.3389/fcimb.2024.1471298}
}
EUVIMED